CN101979036A - Medicinal liquor for treating rheumatic arthritis - Google Patents

Medicinal liquor for treating rheumatic arthritis Download PDF

Info

Publication number
CN101979036A
CN101979036A CN2010105077622A CN201010507762A CN101979036A CN 101979036 A CN101979036 A CN 101979036A CN 2010105077622 A CN2010105077622 A CN 2010105077622A CN 201010507762 A CN201010507762 A CN 201010507762A CN 101979036 A CN101979036 A CN 101979036A
Authority
CN
China
Prior art keywords
grams
rheumatic arthritis
treating rheumatic
radix
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105077622A
Other languages
Chinese (zh)
Inventor
孙勋亚
刘林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010105077622A priority Critical patent/CN101979036A/en
Publication of CN101979036A publication Critical patent/CN101979036A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to medicinal liquor for treating rheumatic arthritis. The medicinal liquor for treating rheumatic arthritis is prepared from 30 grams of safflower, 30 grams of Chinese angelica, 50 grams of long-noded pit viper, 30 grams of scorpion, 25 grams of frankincense, 40 grams of ground beeltle, 40 grams of eucommia bark, 40 grams of ningpo yam rhizome, 40 grams of divaricate saposhnikovia root, 40 grams of clematis root and 40 grams of mulberry twig. The accuracy of weight of the medicaments is +/-10 percent. The medicinal liquor for treating rheumatic arthritis is mainly used for treating rheumatic arthritis, also has good treatment effect on osteoarthritis and chronic infectious arthritis, avoids toxic and side effects, and is remarkable in treatment effect and high in cure rate.

Description

A kind of medicated wine for the treatment of rheumatic arthritis
Technical field
The present invention relates to a kind of medicated wine, specifically is a kind of medicated wine for the treatment of rheumatic arthritis.
Background technology
Rheumatic arthritis is a kind of common acute or chronic ICT.Can show effect repeatedly and involve heart, clinical one miserable with joint and muscle migration, heavily work, pain are feature. belong to allergic disease. be one of main performance of rheumatic fever, how disease such as ache, can not bend and stretch and see with febris acuta and arthralgia, headache, heating, slight perspiration, aversion to wind, heavy sensation of the body, dysuria, joint, the medicine effect is slow at present, some medicine occurs with toxic and side effects, and the long-term prescription medication can cause seriousness infringements such as gastritis, peptic ulcer, liver function injury, renal function injury.
Summary of the invention
In order to solve effective treatment problem to the rheumatic arthritis disease, the invention provides a kind of medicated wine for the treatment of the rheumatic arthritis disease, this medicated wine treatment rheumatic arthritis treating both the principal and secondary aspects of a disease, effect is remarkable.
The concrete important proportioning of the present invention is: Flos Carthami 30 gram, Radix Angelicae Sinensis 30 grams, Agkistrodon 50 grams, Scorpio 30 grams, Olibanum 25 grams, Eupolyphaga Seu Steleophaga 40 grams, the Cortex Eucommiae 40 grams, Rhizoma Dioscoreae Nipponicae 40 grams, Radix Saposhnikoviae 40 grams, Radix Clematidis 40 grams, Ramulus Mori 40 grams, the degree of accuracy of this dose ratio be each medicine ± 10%.
The pharmacology of this medicine is: Flos Carthami: promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing; Radix Angelicae Sinensis: enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation; Agkistrodon: dispel the wind collateral dredging, relieving convulsion; Scorpio: endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain; Olibanum: regulating qi and activating blood, analgesic therapy chases after poison.Control coagulation of QI-blood, trusted subordinate's pain, carbuncle pyogenic infections from tumour or sore, traumatic injury, dysmenorrhea, postnatal blood stasis twinge; Eupolyphaga Seu Steleophaga: removing blood stasis, removing mass, collateral dredging, reason wound and reunion of bone, reducing swelling and alleviating pain, stimulating milk secretion are stimulated the menstrual flow; The Cortex Eucommiae: blood pressure lowering, invigorating the liver and kidney, bone and muscle strengthening; Rhizoma Dioscoreae Nipponicae: relaxing muscles and tendons to promote blood circulation, relieving cough and resolving phlegm, wind-expelling pain-stopping; Radix Saposhnikoviae: expelling pathogenic wind from the body surface, removing dampness to relieve pain, relieving convulsion; Radix Clematidis: expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, expectorant water, the hypochondriac lump of loosing; Ramulus Mori: wind-damp dispelling, sharp joint, row aqueous vapor;
Preparation method of the present invention: Flos Carthami, Radix Angelicae Sinensis, Agkistrodon, Scorpio, Olibanum, Eupolyphaga Seu Steleophaga, the Cortex Eucommiae, Rhizoma Dioscoreae Nipponicae, Radix Saposhnikoviae, Radix Clematidis, Ramulus Mori are mixed into sieve, clear water sieve dash, pull out dry after, mix and immersed 2000 milliliters of Chinese liquor 30 days, get final product patent medicine.
Administrated method: 2 times on the oral one, a 16ml, taking medicine before meal is used; External is applied to the affected part, three times on the one.
The invention has the beneficial effects as follows: the medicated wine of this treatment rheumatic arthritis cures mainly rheumatic arthritis, osteoarthritis, rheumatoid arthritis are also had better curative effect, has no side effect, and is evident in efficacy, the cure rate height.
The specific embodiment
Through over 5 years, the clinical practice to 100 example treatment rheumatic arthritis patients has obtained curative effect preferably, and total effective rate reaches 95%, and details are as follows for relevant clinical treatment situation
1. patient profile: select projects such as medical history, the state of an illness, age, sex and original therapy method.
2. patient originates: with general hospital patient and professional OH patient.
3. case is gone into the group standard, and according to the clinical manifestation and the pathological characters branch of treatment rheumatic arthritis disease, sex, age are not limit; Inactive various other a kind of medicine and therapeutic modalities for the treatment of rheumatic arthritis before the treatment.
4. preparing process: with Flos Carthami, Radix Angelicae Sinensis, Agkistrodon, Scorpio, Olibanum, Eupolyphaga Seu Steleophaga, the Cortex Eucommiae, Rhizoma Dioscoreae Nipponicae, Radix Saposhnikoviae, Radix Clematidis, Ramulus Mori be mixed into sieve, the clear water sieve dashes, pull out dry after, mix and immerse 2000 milliliters of Chinese liquor and got final product patent medicine in 30 days.
5. administrated method: 2 times on the oral one, a 16ml, taking medicine before meal is used; External is applied to the affected part, three times on the one.
6. efficacy evaluation: 1. recovery from illness: joint and muscle migration be miserable, heavy transference cures such as work, pain, thoroughly fully recovers; 2. remarkable: as more than curing later six months recurrence not to be arranged; 3. effective: morbidity significantly reduces; 4. invalid: change not quite before and after the treatment, or once taking a turn for the better, after return to symptom before the treatment again.
7. efficacy analysis:
1. sex: according to going into the group standard, we treat rheumatic arthritis disease patient 100 examples altogether, male's 60 examples (60%) wherein, women's 40 examples (40%).
2. the course of disease: 6 months~1 year is 50 examples, and 1 year~2 years is 30 examples, is 20 examples more than 2 years.
3. age group: 16~20 years old 5 example, 21~30 years old 10 example, 31~40 years old 15 example, 41~50 years old 20 example, 51~60 years old 25 example, 25 examples more than 60 years old.
4. prepare the dose scheme for first kind: Flos Carthami 27 restrains, Radix Angelicae Sinensis 27 restrains, Agkistrodon 45 restrains, Scorpio 27 restrains, Olibanum 22.5 restrains, Eupolyphaga Seu Steleophaga 36 restrains, the Cortex Eucommiae 36 restrains, Rhizoma Dioscoreae Nipponicae 36 restrains, Radix Saposhnikoviae 36 restrains, Radix Clematidis 36 restrains, Ramulus Mori 36 restrains.
The efficacy analysis of this scheme, administration time are 1~3 course of treatment.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 50 examples 40 7 2 1
Moderate patient's 35 examples 30 2 2 1
Severe patient 15 examples 10 2 1 2
The scheme of second kind of preparation dose: Flos Carthami 30 grams, Radix Angelicae Sinensis 30 grams, Agkistrodon 50 grams, Scorpio 30 grams, Olibanum 25 grams, Eupolyphaga Seu Steleophaga 40 grams, the Cortex Eucommiae 40 grams, Rhizoma Dioscoreae Nipponicae 40 grams, Radix Saposhnikoviae 40 grams, Radix Clematidis 40 grams, Ramulus Mori 40 grams.
The efficacy analysis of this scheme, administration time are 1~3 course of treatment.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 45 examples 35 8 1 1
Moderate patient's 40 examples 28 10 1 1
Severe patient 15 examples 8 5 1 1
The scheme of the third preparation dose: Flos Carthami 33 grams, Radix Angelicae Sinensis 33 grams, Agkistrodon 55 grams, Scorpio 33 grams, Olibanum 27.5 grams, Eupolyphaga Seu Steleophaga 44 grams, the Cortex Eucommiae 44 grams, Rhizoma Dioscoreae Nipponicae 44 grams, Radix Saposhnikoviae 44 grams, Radix Clematidis 44 grams, Ramulus Mori 44 grams.
The efficacy analysis of this scheme, administration time are 1~3 course of treatment.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 50 examples 30 15 4 1
Moderate patient's 40 examples 25 10 4 1
Severe patient 10 examples 4 3 2 1
By Drug therapy rheumatic arthritis disease of the present invention, received satisfied curative effect.The symptom of this diseases of whole body is a lot, and this clinical experiment is divided into " slightly ", " moderate " and " seriously " several types according to clinical characters, and this clinical experiment is to carry out jointly at general hospital and special outpatient clinic.
Before this group case treatment, during most of patients was carried out, the treatment of doctor trained in Western medicine mode, but all do not obtain curative effect preferably, especially Western medicine is for oral administration, and side effect is bigger, and human body is caused very major injury, most of patients all are unwilling to accept to take western medicine for a long time, and drug withdrawal voluntarily.In the process of taking Chinese medicine medicine of the present invention, must not take Western medicine and use injection, or other treats this sick medicine.
The medicated wine of this treatment rheumatic arthritis cures mainly rheumatic arthritis, osteoarthritis, rheumatoid arthritis are also had better curative effect, has no side effect, and is evident in efficacy, the cure rate height.

Claims (2)

1. medicated wine for the treatment of rheumatic arthritis, it is characterized in that: concrete proportioning of the present invention is Flos Carthami 30 gram, Radix Angelicae Sinensis 30 grams, Agkistrodon 50 grams, Scorpio 30 grams, Olibanum 25 grams, Eupolyphaga Seu Steleophaga 40 grams, the Cortex Eucommiae 40 grams, Rhizoma Dioscoreae Nipponicae 40 grams, Radix Saposhnikoviae 40 grams, Radix Clematidis 40 grams, Ramulus Mori 40 grams, the degree of accuracy of this dose ratio be each medicine ± 10%.
2. medicated wine for the treatment of rheumatic arthritis, it is characterized in that: preparation technology of the present invention sieves and dashes for Flos Carthami, Radix Angelicae Sinensis, Agkistrodon, Scorpio, Olibanum, Eupolyphaga Seu Steleophaga, the Cortex Eucommiae, Rhizoma Dioscoreae Nipponicae, Radix Saposhnikoviae, Radix Clematidis, Ramulus Mori being mixed into sieve, clear water, pull out and dry, mix 2000 milliliters of Chinese liquor of immersion and got final product patent medicine in 30 days.
CN2010105077622A 2010-10-11 2010-10-11 Medicinal liquor for treating rheumatic arthritis Pending CN101979036A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105077622A CN101979036A (en) 2010-10-11 2010-10-11 Medicinal liquor for treating rheumatic arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105077622A CN101979036A (en) 2010-10-11 2010-10-11 Medicinal liquor for treating rheumatic arthritis

Publications (1)

Publication Number Publication Date
CN101979036A true CN101979036A (en) 2011-02-23

Family

ID=43599591

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105077622A Pending CN101979036A (en) 2010-10-11 2010-10-11 Medicinal liquor for treating rheumatic arthritis

Country Status (1)

Country Link
CN (1) CN101979036A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105902797A (en) * 2016-06-30 2016-08-31 田引娣 Medicine for treating rheumatic arthritis
CN108452121A (en) * 2018-05-21 2018-08-28 樊有山 A kind of medicinal liquor for treating rheumatism
CN112426510A (en) * 2020-12-04 2021-03-02 广西冠硕科技有限公司 Formula for treating arthritis and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105902797A (en) * 2016-06-30 2016-08-31 田引娣 Medicine for treating rheumatic arthritis
CN108452121A (en) * 2018-05-21 2018-08-28 樊有山 A kind of medicinal liquor for treating rheumatism
CN112426510A (en) * 2020-12-04 2021-03-02 广西冠硕科技有限公司 Formula for treating arthritis and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101007040B (en) External applied medicine for treating bone fractures
CN101983717A (en) Traditional Chinese medicine for treating migraine
CN101983644A (en) Medicament for treating sequelae of apoplexy
CN101979036A (en) Medicinal liquor for treating rheumatic arthritis
CN1325110C (en) Medicated wine for treating traumatic injury
CN101983672A (en) Medicament for treating cramp
CN102406870B (en) Medicament for treating rheumatic arthralgia
CN101181427B (en) Externally used medicament for curing scaly tetter
CN101983650A (en) Medicament for treating dermatitis aestivale
CN101961455A (en) Traditional Chinese medicine for treating chronic colitis disease
CN101983682A (en) Medicament for treating female climacteric metancholia
CN102078432A (en) Medicament for treating skin itch
CN112245494A (en) External medicine for treating gout and preparation method thereof
CN104524107A (en) Chinese patent medicine for wind cold damp impediment symptom
CN1181879C (en) Analgestic plaster
CN104491313A (en) Medicine for treating dampness-heat arthromyodynia
CN104474153A (en) Medicine used for diminishing inflammation, relieving pain,eliminating blood stasis and promoting tissue regeneration
CN104189273A (en) Traditional Chinese medicine used for treating thrombophlebitis
CN101983681A (en) Medicament for treating abnormal leucorrhea
CN103690833B (en) A kind of Chinese medicine for the treatment of rheumatic arthritis
CN101983645A (en) Medicament for treating acute appendicitis
CN102357130B (en) Chinese herbal medicine composition for treating rheumatism
CN101983676A (en) Medicament for treating gynecological blood stasis and qi stagnation
CN101953943A (en) Traditional Chinese medicine for treating chronic aplastic anemia
CN103877348A (en) Traditional Chinese medicine preparation for treating periostitis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110223